SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ALX Oncology Q3 net loss per share narrows 63% to $0.15

ALX Oncology Q3 net loss per share narrows 63% to $0.15 ALX Oncology’s third-quarter 2026 net lo

ALXO

Related stories